HIV infection and antiphospholipid antibody: Literature review and link to the antiphospholipid syndrome

AIDS Patient Care and STDs

Volumn 18, Issue 6, 2004, Pages 333-340

  Hassoun, Ali ^a,c   Al Kadhimi, Zaid ^b   Cervia, Joseph ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b City of Hope Medical Center   (United States)

^c Apt #2 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTITHROMBIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT; D DIMER; HEPARIN; HEPARIN COFACTOR II; IMIPENEM; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; LUPUS ANTICOAGULANT; NELFINAVIR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN; PREDNISONE; PROTEIN C; PROTEIN S; VANCOMYCIN; VON WILLEBRAND FACTOR; WARFARIN; ZIDOVUDINE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PARTIAL THROMBOPLASTIN TIME; REVIEW; SKIN BIOPSY; SKIN NECROSIS; WESTERN BLOTTING;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HIV INFECTIONS; HUMANS; MALE; NECROSIS; SKIN DISEASES; THROMBOSIS;

EID: 3042688152     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/1087291041444032     Document Type: Review

References (51)

1. Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 2000;14:321.
2. Sloand EM, Klein HG, Banks SM, et al. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 1992;48:168.
3. Peltier JY, Lambin P, Doinel C, et al. Frequency and prognostic importance of thrombocytopenia in symptom free HIV infected individual: A 5 year prospective study. AIDS 1991;5:381.
4. Glatt AE, Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: Treatment update. Clin Infect Dis 1995;21:415.
5. Saif MW, Greenberg B. HIV and thrombosis: A review. AIDS Patient Care STDS 2001;15:15-24.
6. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449.
7. Ankri A, Bonmarchand M, Coutellier A, et al. Antiphospholipid antibodies are an epiphenomenona in HIV infected patients. AIDS 1999;13:1282.
8. Coll Daroca J, Gutierrez-Cebollada J, Yazbeck H, et al. Anticardiolipin antibodies and acquired immunodeficiency syndrome: Prognostic marker or association with HIV infection? Infection 1992;20:140.
9. Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986;256:491.
10. Cohen AJ, Philips TM, Kessler CM. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:175.
11. Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623.
12. Vila P, Hernandez MC, Lopez-Fernandez MF, Battle J. Prevalence, follow up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209.
13. Petri M. Pathogenesis and treatment of antiphospholipid syndrome. Med Clin North Am 1997;81:151.
14. Santoro SA. Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenic mechanisms. Blood 1994;83:2389.
15. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685.
16. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: Clinical and Immunologic manifestations and Patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019.
17. Gonzalez C, Leston A, Garcia-Berrocal B, et al. Antiphosphatidylserine antibodies in patient with autoimmune diseases and HIV infected patients: Effect of Tween 20 and relationship with antibodies to beta 2 glycoprotein I. J Clin Lab Anal 1999;13:59.
18. Goodnight SH. Antiphospholipid antibodies and thrombosis. Curr Opin Hematol 1994;1:354.
19. Roubey RA. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444.
20. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752.
21. Bermas BL, Schur PH. Clinical manifestation and diagnosis of antiphospholipid antibody syndrome. Up-Todate 2002;10:1-9.
22. Petri M. 1998 update on antiphospholipid antibodies. Current Opin Rheumatol 1998;10:426.
23. Greaves M, Cohen H, Machin SJ, Mackie I. Guideline on the investigation and management of antiphospholipid syndrome. Br J Haematol 2000;109:704.
24. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42:1309.
25. Mcnally T, Purdy G, Mackie IJ, et al. The use of antibeta2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471.
26. Asherson RA, Mercy D, Philips G, et al. Recurrent stroke and multi-infarct dementia in SLE associated with antiphospholipid antibodies. Ann Rheum Dis 1987;46:605.
27. Brey RL, Abbott RD, Curb JD, et al. Beta2 Glycoprotein I-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu heart program. Stroke 2001;32:1701.
28. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to pathogenesis from a series of 80 patients. Medicine 2001;80:355.
29. Asherson RA, Cervera R. Review: Antiphospholipid antibodies and the lung. J Rheumatol 1995;22:62.
30. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks Endocarditis) in the antiphospholipid syndrome. Circulation 1996;93: 1579.
31. Kniaz D, Eisenberg GM, Elrad H, et al. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. A case report and review of the literature. Am J Nephrol 1992;12:126.
32. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994;23:357.
33. Gibson GE, Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997; 36:970.
34. Soweid A, Hajjar R, Hewan-Lowe KD, Gonzalez EB. Skin necrosis indicating antiphospholipid syndrome in patient with AIDS. South Med J 1995;88:786.
35. Smith K, Skelton HG, Yeager J. Cutaneous thrombosis in human Immunodeficiency virus type 1-positive patients and cytomegalovirus viremia. Arch Dermatol 1995;131:357.
36. Bermas BL, Schur PH, Kaplan AA. Prognosis and therapy of the antiphospholipid antibody syndrome. UpTodate 2002;10:No. 2, 1-6.
37. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993.
38. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998;104:332.
39. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001;60:500.
40. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM. Antiphospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmune 1999;13:347.
41. De Larranaga GF, Forastiero RR, Carreras LO, Alonso BS. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999;96:19.
42. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounting for infectious etiology if antiphospholipid syndrome. J Clin Invest 2002;109:797.
43. Silvestris F, Frassanito MA, Cafforio P, et al. Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody dependent cellular cytotoxicity. Blood 1996;87:5185.
44. Lafeuillade A, Alessi MC, Poizot-Martin I, et al. Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 1992;5:127.
45. Gross PL, Aired WC. The endothelium and thrombosis. Semin Thromb Hemost 2000;26:463.
46. Sorise M, Griggi T, Arceiri P, et al. Protein S and HIV infection. The role of anticardiolipin and antiprotein S antibodies. Thromb Res 1994;73:165.
47. Constans J, Guerin V, Couchouron A, et al. Autoantibodies directed against phospholipids or human beta2-glycoprotein I in HIV seropositive patients: Relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 1998;28:115.
48. Stimmler MM, Quismorio FP, McGehee QG, et al. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989;149:1833.
49. Abuaf N, Laperche S, Rajoaely B, et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997;77:856.
50. Falco M, Sorrenti A, Priori R, et al. Anticardiolipin antibodies in HIV are true antiphospholipid not associated with antiphospholipid syndrome. Ann Ital Med Int 1993;8:171.
51. Karmochkine M. Plasma hypercoagulability is correlated to plasma HIV load. Thrombosis Haemost 1998;80:208.